Lifeboat Foundation

Shift Robotics is set to introduce its latest innovation, the Moonwalkers X, at CES 2024, showcasing advancements that make these robotic shoes significantly lighter, quicker, and smarter than their predecessor.

The Moonwalkers X, with six wheels instead of 10, is poised to redefine the landscape of commercial mobility. Xunjie Zhang, CEO and founder of Shift Robotics, expressed excitement about the upcoming launch, stating, “With Moonwalkers X, we’ve redefined lightweight mobility by trimming nearly a pound from the original design.”

Xerox was once a synonym for copying. But those halcyon days are long gone for the office equipment company founded in 1906.

Now the company plans to cut 15% of its workforce in the first three months of this year as part of its “reinvention” plans.

Xerox has about 23,000 staff, according to its annual report, meaning thousands will be let go.

All these previous innovations pale in the face of tools like MidJourney, DALL-E, and Adobe Firefly.

These generative AI image systems, the kind that easily spits out this image below of a flooded downtown Manhattan, are dream weavers that make the literal out of the imagined.

When Midjourney builds an image, there are no easily identifiable sources, mediums, or artists. Every pixel can look as imaginary or real as you want and when they leave the digital factory, these images (and video) travel fleetfooted around the world, leaving truth waiting somewhere in the wilderness.

Four times now, researchers have produced a fleeting burst of fusion energy, an encouraging sign for making this zero-carbon energy source a reality.

Just like a doctor adjusts the dose of a medication to the patient’s needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window. Staying within the therapeutic window is important as too much of the protein could be toxic, and too little could result in a small or no therapeutic effect.

Although the principle of therapeutic window has been known for a long time, there has been no strategy to implement it safely, limiting the potential applications of gene therapy in the clinic.

In their current study published in the journal Nature Biotechnology, researchers at Baylor College of Medicine report on a technology to effectively regulate gene expression, a promising solution to fill this gap in gene therapy clinical applications. A Research Briefing on the breakthrough has been published in the same journal issue.

Unlike older methods that use things foreign to our bodies, this one doesn’t trigger our immune system and employs small molecules to interact with RNA.

Researchers at Baylor College of Medicine have developed a breakthrough technology to regulate gene expression in gene therapy, addressing the crucial issue of maintaining therapeutic gene levels within a safe range.

This is important because having too much or too little of a gene’s activity within a therapeutic window can cause problems. Their method uses tiny substances in amounts approved by the FDA to control the genes.

Continue reading “Gene on/off? New tech lets scientists control genes like a light switch” »

There has been a lot of publicity on generative AI “chat bot” innovations across North America; OpenAI’s ChatGPT4, Google’s Bard, and most recently AmazonQ are all at the competitive generative AI trough.

This blog highlights China’s ERNIE Bot, and other leading chat bots and provides insights on the generative AI chat bot market.

From mRNA technology to T cell engagers, there were a number of advancements in cancer research in 2023.

The use of artificial intelligence by the general population in developed countries such as the US to a “significant” degree will start to take place in the next 18 to 24 months, according to Microsoft co-founder and philanthropist Bill Gates in his year-end letter released last week.

The impact on things such as productivity and innovation could be unprecedented, says Gates.

“Artificial intelligence is about to accelerate the rate of new discoveries at a pace we’ve never seen before,” wrote Gates on his blog.